Essential technology for sub-ppm mass accuracy and high-resolution untargeted metabolomics
In this webinar, Dr. Chris Petucci will provide an overview of the University of Pennsylvania Metabolomics Core and how it performs targeted and untargeted LC/MS metabolomics for internal and external research investigators and industry.
One of the platform’s key enabling technologies for in-depth understanding of biological pathways in disease and biomarker discovery is the Thermo Scientific™ Orbitrap ID-X™ Tribrid™ mass spectrometer.
Examples of sample preparation, LC/MS method development, and untargeted metabolomics projects in medical research will be presented to illustrate the power of the Orbitrap ID-X mass spectrometer.
This webinar will cover the following:
Stable and reproducible sample preparation of cells, biological fluids, and tissues for metabolomics
Essentials of chromatography theory and practice for high-resolution chromatography of metabolites
Strengths of the Orbitrap ID-X LC/MS for untargeted metabolomics
Basics of statistical data analysis of untargeted metabolomics data using Thermo Scientific™ Compound Discoverer™ software
Who should attend?
Research scientists in the metabolomics field, especially those who use mass spectrometry, including people who are new to the metabolomics field as well as experts who want to learn more about accurate and precise sample preparation, LC/MS experiments, and data analysis for untargeted metabolomics with the Orbitrap ID-X LC/MS.
Presenter: Dr. Chris Petucci (Director of the Metabolomics Core, University of Pennsylvania)
Chris Petucci received his Ph.D. in analytical chemistry with a focus on mass spectrometry from Purdue University. After his time in drug discovery at Wyeth, he established and became the director of a targeted metabolomics core at the Sanford Burnham Prebys Medical Discovery Institute. The core was a major partner with the Southeast Center for Integrated Metabolomics (SECIM) at the University of Florida, one of six National Institutes of Health (NIH) sponsored national centers to spur metabolomics research. He is currently the director of the Penn Metabolomics Core of the Cardiovascular Institute at the Perelman School of Medicine. The core performs targeted and untargeted metabolomics assays for biomarker discovery to serve internal and external research investigators, including industry.
Presenter: Moderator: Charlie Carter (Editorial Team, SelectScience)
Charlie studied neuroscience at the University of Bristol, UK, before completing a Masters in Science Communication. As a member of the Editorial team, Charlie plays an integral role in shaping the content on SelectScience.
